Cleveland BioLabs taps BioProcess Capital's Kasimova for board
Biopharmaceutical company Cleveland BioLabs Inc has appointed Elena Kasimova to its board of directors. Kasimova is a director of strategy and investment at BioProcess Capital Partners.
Biopharmaceutical company Cleveland BioLabs Inc has appointed Elena Kasimova to its board of directors. Kasimova is a director of strategy and investment at BioProcess Capital Partners.